Based on ratings from 0 stock analysts, the Abacus Life Inc stock price is expected to increase by 43.74% in 12 months. This is calculated by using the average 12-month stock price forecast for Abacus Life Inc. The lowest target is $12 and the highest is $16. Please note analyst price targets are not guaranteed and could be missed completely.
ABL is a stock in Financial Services which has been forecasted to be worth $14 as an average. On the higher end, the forecast price is $16 USD by Matt Howlett from B. Riley Securities and on the lower end ABL is forecasted to be $12 by Crispin Love from Piper Sandler.
These are the latest 20 analyst ratings of ABL.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Matt Howlett B. Riley Securities | Buy | $16 | Reiterates | Aug 29, 2024 |
Andrew Kilgerman TD Cowen | Buy | $14 | Initiates | Aug 7, 2024 |
Crispin Love Piper Sandler | Overweight | $12 | Initiates | Jun 26, 2024 |
Matt Howlett B. Riley Securities | Buy | $15 | Reiterates | Jun 24, 2024 |
Matt Howlett B. Riley Securities | Buy | $16 | Initiates | May 31, 2024 |
When did it IPO
2023
Staff Count
102
Country
United States
Sector/Industry
Financial Services/Insurance - Life
CEO
Mr. Jay J. Jackson
Market Cap
$701.7M
In 2023, ABL generated $66.4M in revenue, which was a increase of 48.50% from the previous year. This can be seen as a signal that ABL's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Abacus Life, Inc. (ABL) is being evaluated as a potential top stock pick for momentum investors. Further analysis is needed to determine its suitability.
Why It Matters - The inquiry into Abacus Life, Inc.'s momentum potential indicates growing interest, suggesting possible volatility and investment opportunities that could influence stock performance.
Summary - Analysts' price targets for Abacus Life, Inc. (ABL) suggest a 34.6% potential upside, supported by consensus increases in earnings estimates.
Why It Matters - Analysts' price targets suggest significant upside for Abacus Life, indicating potential growth. Consensus on earnings estimates further supports positive sentiment around the stock.
Summary - Abacus Life, Inc. (ABL) saw a rise in share price with above-average trading volume, and recent earnings estimate revisions indicate potential future strength.
Why It Matters - Abacus Life's share price increase and above-average trading volume indicate strong market interest, while positive earnings estimate revisions suggest potential future growth.
Summary - Investors should consider low-beta stocks for stability in a volatile market. Notable candidates include ERIE, SFM, AVO, and ABL.
Why It Matters - Low-beta stocks like ERIE, SFM, AVO, and ABL can provide stability and preserve capital during market volatility, making them attractive options for risk-averse investors seeking resilience.
Summary - Abacus Life, Inc. (NASDAQ: ABL) has appointed Corey McLaren as Managing Director of Capital Markets, enhancing its leadership in lifespan-based financial products.
Why It Matters - Corey McLaren's appointment could enhance Abacus Life's strategic direction and capital market operations, potentially improving investor confidence and driving stock performance.
Summary - Abacus Life, Inc. (NASDAQ: ABL) reports its Policy Value Calculator has exceeded 150,000 submissions, representing over $87 billion in face value, indicating strong engagement with its financial products.
Why It Matters - Abacus Life's Policy Value Calculator growth indicates strong demand for its products, potentially boosting revenue and market position, influencing investor confidence and stock performance.